As part of its continuing effort to buttress food and medical product safety in this country by working with its regulatory partners overseas, the US Food and Drug Administration has announced the opening of its Mexico City post.
“The opening of this office represents an important step as we re-design our product safety strategy,” said FDA commissioner Margaret Hamburg.
“We, like our partners in the Mexican Government, realize that prevention is the key. For example, more than a third of the fresh fruits and vegetables we eat come from Mexico as do a large amount of our medical devices. Having FDA experts located permanently there will be mutually beneficial to both our countries and respective citizens.”
Staff assigned to the FDA’s Mexico City post will work with their counterparts in the Mexican government to harmonize regulations and guidance standards and to work on other collaborative initiatives.
These collaborations will include, for example, information-sharing on the respective regulatory systems and joint workshops on the safety of food and medical products. Agencies in both governments also will make efforts to find opportunities for joint training on food-borne illnesses and the oversight of food traded internationally.
FDA staff also will offer collaboration on the use of the latest laboratory techniques, foster other collaborative initiatives to ensure the safety of food and medical products marketed in the two countries, and be a “portal” to the FDA for counterpart Mexican agencies and the US-export industry in Mexico.
“FDA staff will work with industry in Mexico as well,” said Murray Lumpkin, US FDA Deputy Commissioner for International Programs.
“FDA experts in Mexico City will work closely with local industries that ship food and medical products to the United States to improve their understanding of US safety and product quality expectations. Their activities will include providing technical advice and working with government agencies and the private sector to develop certification programs.”
To date, the FDA has opened 10 international posts, including posts in China, India, Europe, and Latin America, along with its US-based staff.
The other posts in the Latin America Office are located in Santiago, Chile, and at the FDA’s Latin America Office headquarters in San José, Costa Rica.
